SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-003538
Filing Date
2023-01-12
Accepted
2023-01-12 21:02:39
Documents
1
Period of Report
2023-01-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm231655-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm231655-7_4seq1.xml 4 8325
  Complete submission text file 0001104659-23-003538.txt   9900
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address
Lunger John (Reporting) CIK: 0001784487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 23526990